Related Experiment Video
Updated: May 20, 2026
03:07
Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
[Measures to reduce high-dose multiple antipsychotics in Japan]
1National Hospital Organization Tottori Medical Center.
Summary
This study introduces a slow-dose reduction method for antipsychotic drugs in schizophrenia patients, significantly lowering medication complexity and improving patient outcomes. The approach demonstrated a high rate of successful monotherapy, suggesting a safer treatment paradigm.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Neuroscience
Context:
- High-dose, polypharmacy antipsychotic treatment is common for schizophrenia in Japan.
- This regimen is associated with frequent extrapyramidal and autonomic side effects.
- Concomitant use of anticholinergic agents and cathartics may worsen patient prognosis.
Purpose:
- To propose and evaluate a slow-dose reduction method for antipsychotic medications in schizophrenia patients.
- To assess the safety and efficacy of gradual antipsychotic tapering.
- To reduce polypharmacy and high-dose prescriptions in schizophrenia treatment.
Summary:
- A slow-dose reduction protocol was implemented: low-potency antipsychotics decreased by ≤25 mg/week chlorpromazine equivalent, high-potency by ≤50 mg/week.
- In a cohort, patients averaged 1.26 antipsychotics (SD: 0.50) at 527 mg chlorpromazine equivalent (SD: 297 mg), achieving 70% monotherapy.
- A randomized controlled trial confirmed the safety and feasibility of this reduction method.
Impact:
- This method offers a potential solution to the challenges of high-dose, multiple-drug administration in schizophrenia.
- Widespread adoption could improve patient prognoses and reduce adverse drug events.
- Facilitates prescription reform towards more individualized and safer antipsychotic regimens.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...